Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancers

Medicinal Research Reviews - Tập 32 Số 2 - Trang 326-348 - 2012
Ke Zen1, Chen‐Yu Zhang
1Jiangsu Diabetes Center, State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu 210093, China.

Tóm tắt

AbstractSpecific and sensitive non‐invasive biomarkers for the detection of human epithelial malignancies are urgently required to reduce the worldwide morbidity and mortality caused by cancer. MicroRNAs (miRNAs) are 19–24 nt noncoding RNAs that are frequently dysregulated in cancer and have shown great promise as tissue‐based markers for cancer classification. Once thought to be unstable RNA molecules, miRNAs are now shown to be stably expressed in serum, plasma, urine, saliva, and other body fluids. Moreover, the unique expression patterns of these circulating miRNAs are correlated with certain human diseases, including various types of cancer. Therefore, tumor‐derived miRNAs in serum or plasma are emerging as novel blood‐based fingerprints for the detection of human cancers, especially at an early stage. This review presented newly uncovered cellular and molecular mechanisms of the sources and stability of circulating miRNAs, revealing their great potential as a class of highly specific and sensitive biomarkers for tumor classification and prognostication. Meanwhile, this review also addressed certain critical issues that hinder the wide application of this new approach. Some potential challenges for the transition of circulating miRNAs from a research setting to a clinical application were also highlighted, with a future perspective of the incorporation of circulating miRNAs in the field of clinical oncology, especially their great potential from diagnostic to prognostic and predictive applications.  © 2010 Wiley Periodicals, Inc. Med Res Rev

Từ khóa


Tài liệu tham khảo

10.1002/1097-0142(20001201)89:11 <2334::AID-CNCR4>3.0.CO;2-I

10.1038/nbt1235

10.1093/biostatistics/4.4.523

10.1093/jnci/dji430

10.1056/NEJMoa060476

10.2214/AJR.05.0088

10.1093/jnci/djn172

10.2174/1874189400701010001

Schneider J, 2000, Comparison of the tumor markers tumor M2‐PK, CEA, CYFRA 21‐1, NSE and SCC in the diagnosis of lung cancer, Anticancer Res, 20, 5053

Huber K, 1992, Determination of plasma urokinase‐type plasminogen activator antigen in patients with primary liver cancer: characterization as tumor‐associated antigen and comparison with alpha‐fetoprotein, Cancer Res, 52, 1717

10.1002/jcp.20195

10.1080/15216540600719598

10.1200/JCO.2007.14.2364

10.1006/scbi.1998.0086

10.1038/sj.bjc.6603188

10.1373/clinchem.2009.127878

10.1373/clinchem.2009.127019

10.1021/pr015509n

10.1038/nature01031

10.1016/j.ymeth.2008.05.005

10.1016/S0092-8674(04)00045-5

10.1038/nrc1840

Heneghan HM, 2009, MicroRNAs as novel biomarkers for breast cancer, J Oncol, 2009, 950201

10.1038/nrg2634

10.1073/pnas.242606799

10.1158/0008-5472.CAN-09-1448

10.1002/hep.22838

10.1053/j.gastro.2007.05.022

10.1073/pnas.0500613102

10.1073/pnas.0703942104

10.1038/ncb1722

10.1053/j.gastro.2006.02.057

10.1158/0008-5472.CAN-07-1936

10.1158/1078-0432.CCR-07-1755

10.1016/j.molcel.2009.09.008

10.1073/pnas.0510565103

10.1038/cr.2008.282

10.1073/pnas.0804549105

10.1038/cdd.2009.105

10.1146/annurev.med.59.053006.104707

10.1016/j.ccr.2006.01.025

10.1158/0008-5472.CAN-06-2698

10.1182/blood-2006-09-045104

10.1038/sj.onc.1210228

10.1038/nrc1997

10.1158/0008-5472.CAN-06-0800

10.1158/0008-5472.CAN-08-4710

10.1038/ncb1800

10.1016/j.ccr.2008.10.005

10.1038/nbt1392

10.1073/pnas.0511155103

10.1158/0008-5472.CAN-05-1783

10.1371/journal.pone.0002436

10.1038/nature03702

10.1016/j.ygyno.2008.03.023

10.1016/j.ydbio.2006.08.028

10.1261/rna.642907

10.1186/1472-6750-7-36

10.1111/j.1365-2141.2008.07077.x

10.1101/gr.074740.107

10.1016/j.ymeth.2007.09.009

10.1186/1471-2164-10-563

10.1186/gb-2009-10-7-r78

10.1186/1756-0500-2-89

10.3816/CLC.2009.n.006

10.1158/1078-0432.CCR-07-0992

10.1016/j.ygyno.2008.04.033

10.1136/gut.2008.167817

10.1371/journal.pone.0006229

Ai J, 2009, Circulating microRNA‐1 as a potential novel biomarker for acute myocardial infarction, Biochem Biophys Res Commun

10.1373/clinchem.2009.125310

10.1073/pnas.0813371106

10.1373/clinchem.2009.131797

10.1016/j.bbrc.2010.02.145

10.1161/CIRCRESAHA.110.218297

10.1093/eurheartj/ehq013

10.1371/journal.pone.0003148

10.1373/clinchem.2007.097972

HankeM HoefigK MerzH FellerAC KauschI JochamD WarneckeJM SczakielG.A robust methodology to study urine microRNA as tumor marker: microRNA‐126 and microRNA‐182 are related to urinary bladder cancer.Urol Oncol: Seminars and Original Investigations in press.

10.1158/1078-0432.CCR-09-0736

10.1111/j.1601-0825.2009.01604.x

10.1016/j.ab.2009.01.037

10.1016/j.bbrc.2006.02.106

10.1021/ac8026788

10.1373/clinchem.2007.101741

10.1261/rna.939908

10.1200/JCO.2009.24.9342

10.1016/j.ymeth.2010.01.032

10.1074/jbc.M805607200

10.4049/jimmunol.0802002

10.1083/jcb.200807034

10.1586/epr.09.17

10.1161/01.HYP.0000231507.00962.b5

10.1161/01.CIR.99.3.348

10.1161/01.CIR.101.8.841

10.4049/jimmunol.166.12.7309

10.1074/jbc.M404850200

10.1038/nri855

10.1084/jem.183.3.1161

10.1038/ncb1596

10.1371/journal.pone.0003694

10.1242/jcs.113.19.3365

10.1096/fj.03-1094fje

10.1158/1078-0432.CCR-04-1688

10.1038/onc.2009.211

10.1002/hep.22806

10.1016/j.lungcan.2004.12.008

10.1016/S0140-6736(97)02174-0

10.1080/00313020701230831

10.1126/science.1163728

10.1126/science.1107130

10.1093/nar/gkp031

10.1038/nature08433

10.1101/gad.1761509

10.1038/ncb1931

10.1016/j.molcel.2005.10.020

10.1182/blood-2003-03-0713

10.1016/j.cell.2005.10.022

10.1038/nature03868

10.1038/nature02123

10.1038/ncb1929

10.1038/cr.2008.290

10.2174/156652410790963295

Thông tin
Thông tin xuất bản

Medicinal Research Reviews

Tập 32 Số 2

326-348

Thông tin tác giả